Hematologist
CION Cancer Clinics
When APL comes back: treatment options and next steps | CION Cancer Clinics
Relapsed acute promyelocytic leukaemia (APL) can often be brought back into remission, especially when a follow-up gene test catches it early. Treatment usually restarts with ATRA and arsenic trioxide, adjusted to what you had the first time. Once the gene test is negative again, a stem cell transplant may be discussed. This page explains the kinds of relapse, the steps that follow and the questions to take to your haematologist. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can APL be treated again if it comes back?
- What kinds of relapse are there?
- What happens after relapse is found?
- How does your first treatment shape the next one?
- What do families fear about relapse that is not true?
- What should you ask, and what can this page not tell you?
- Common questions about relapsed APL
The short answer
Can APL be treated again if it comes back?
Yes. Relapsed APL can often be brought back into remission, meaning no leukaemia can be found, especially when the return is caught early on a gene test. The plan usually switches to the medicines you did not receive the first time, and a stem cell transplant is often discussed.
What relapse means
Relapse means the leukaemia has come back after a period of remission. In APL it is uncommon, and it is most likely in the first years after treatment. It is often found before any symptoms, because the PML-RARA gene test turns positive again during follow-up.
Why the first treatment still matters
Your team will look closely at what you had before. If your first treatment was ATRA with chemotherapy, arsenic trioxide is usually the main medicine now. If you already had ATRA with arsenic trioxide, the team may add chemotherapy or other medicines. How long you stayed in remission also shapes the choice.
Who this page does not suit
If the leukaemia never went into remission after the first treatment, that is a different situation, called refractory disease. The questions and options overlap, but your haematologist will explain a separate plan.
Do not restart any old APL medicines you have at home. The new plan must be set by your treating team.How it is found
What kinds of relapse are there?
The type affects how urgent the next step is and which tests come first.
Molecular relapse
The gene test turns positive again, but blood counts and the marrow under the microscope still look normal. This is the earliest point to find a relapse, and the test is usually repeated to confirm it.
Starting treatment at this stage is often simpler and safer.Haematological relapse
APL cells are seen again in the blood or marrow. Counts may fall, and the clotting problem can return, so this is treated as urgent.
Signs that may appear
- Easy bruising or bleeding
- Tiredness and paleness
- Fevers or infections
Relapse outside the marrow
Rarely, APL returns in the brain and spinal fluid or elsewhere. Headaches, confusion or new weakness need checking, and a sample of spinal fluid may be tested.
Not sure whether this applies to you?
Ask an oncologist
!
The one thing that cannot wait
When APL returns, the dangerous bleeding problem can return with it. A sudden severe headache, confusion, vomiting blood, black stools, a heavy nosebleed or bleeding that will not stop is an emergency. Go to the nearest emergency department now, or call 108, and tell them the person has had APL. Do not wait for a planned appointment.
The pathway
What happens after relapse is found?
-
Confirming the result
A positive gene test is usually repeated, and a marrow test is often done. Clotting tests and blood counts show how urgent things are.
-
Starting treatment again
ATRA and arsenic trioxide form the base of most plans, with chemotherapy or other medicines added depending on your first treatment. The early weeks are watched as closely as the first time.
-
Checking the response
The aim is a second remission where the gene test turns negative. This result shapes every decision that follows.
-
The transplant discussion
If the gene test is negative, a transplant using your own stem cells may be considered. If it stays positive, a transplant from a donor may be discussed. Some people continue without a transplant.
-
Long-term follow-up
Gene tests continue for years, often more closely than after the first treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
How does your first treatment shape the next one?
First treatment was ATRA with chemotherapy
First treatment was ATRA with arsenic trioxide
Arsenic trioxide is usually the main medicine now
Chemotherapy or other medicines are often added
Heart checks matter, as earlier chemotherapy can affect the heart
Heart rhythm checks continue during any arsenic courses
Transplant is discussed once the gene test turns negative
Transplant is discussed once the gene test turns negative
Commonly believed
What do families fear about relapse that is not true?
"Relapse means the first treatment was done wrongly."
Relapse can happen even after excellent treatment. A small number of cells can survive below what tests can detect. It is not a sign that you, your family or the doctors made a mistake.
"A positive gene test means we must go abroad."
The main medicines for relapsed APL are available in India, and transplants are done at qualified centres here. Ask your haematologist what is needed before planning travel.
"If he feels fine, the positive test can be ignored."
A molecular relapse usually causes no symptoms at first. Treating it at this stage, before bleeding or low counts return, is often the safer path. Ignoring it can let it grow.
"Transplant is the only option now."
A transplant is one option, not the only one. Some people reach a lasting second remission with medicines alone. The choice depends on your gene test, age, health and wishes.
Being straight with you
What should you ask, and what can this page not tell you?
This page cannot tell you how your relapse will respond, which medicines suit you or whether you need a transplant. Those answers come from your gene test, your previous treatment and your general health.
Questions to take to your haematologist
Ask whether this is a molecular or haematological relapse. Ask what the plan is and why it differs from last time. Ask what the next gene test must show, and whether a transplant is being considered. If a transplant is mentioned, ask which qualified centre would do it, what tests are needed first and whether a family member may be asked to be tested as a donor.
How CION can help
CION does not perform stem cell transplants. CION's haematology team reviews the reports, presents the case to a tumour board, explains the options in plain language and coordinates care with qualified transplant centres where needed. Bring your full treatment summary from the first time.
Looking after the family too
A relapse often means more hospital visits, more travel from the district and more time off work for whoever comes along. Talk openly about who will stay with the patient, who handles paperwork and who speaks with the doctors. Sharing the load early helps everyone manage the months ahead.
Hearing about relapse is hard for the whole family. It is fine to ask for the plan to be explained twice.Questions we are asked
Common questions about relapsed APL
How is relapsed APL usually found?
Most often through a follow-up PML-RARA gene test that turns positive again while the person still feels well. Sometimes it shows up as falling counts, bruising or bleeding. This is why follow-up tests matter even years after treatment, and why any new bleeding should be checked quickly.
Is relapsed APL treated in hospital again?
Often, yes, at least at the start, especially if counts are low or clotting is abnormal. A relapse found early on the gene test alone may allow more of the treatment to be given in day care. Your team decides based on your blood tests and how you are feeling.
What is an autologous stem cell transplant?
It uses your own stem cells, collected once the gene test is negative. High-dose treatment is given, and the stored cells are returned to help the marrow recover. It is usually considered only when the leukaemia is undetectable, and it is done at a qualified transplant centre.
When is a donor transplant suggested?
A transplant from a matched donor, often a brother or sister, may be discussed if the gene test stays positive or APL returns again. It carries more risks than using your own cells, so it is weighed carefully against age, health and other options. Ask what testing a sibling would need.
Will differentiation syndrome happen again?
It can. This reaction to ATRA or arsenic trioxide may cause breathlessness, fever, swelling or weight gain, and it can occur during retreatment just as it did the first time. Tell the team at once about any new breathing difficulty, even if it seems mild.
Can the brain be affected when APL comes back?
Rarely, yes. APL can return in the fluid around the brain and spinal cord. Your team may test that fluid, especially if there are headaches or other nerve symptoms, and add treatment aimed at that area. Report any new headache, confusion or weakness promptly.
Does Aarogyasri or insurance cover relapse treatment?
Many schemes and policies include leukaemia treatment, and some cover transplants at empanelled centres. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurers each have their own rules, which change. Ask the helpline to check your current cover before admission if time allows.
Should we get a second opinion after relapse?
It is reasonable, as long as it does not delay urgent treatment. Bring the full first treatment summary, every gene test report and recent counts. A second opinion is most useful for the transplant question, which usually has a little more time than the start of treatment.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- American Cancer Society — Acute Myeloid Leukemia (AML)
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia
- Cancer Research UK — Acute myeloid leukaemia (AML)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
APL Maintenance and Follow-Up MonitoringThe follow-up tests that usually find relapsePML-RARA: The Test That Confirms APLWhat a positive gene test meansDifferentiation Syndrome: A Reaction to Watch ForA reaction that can happen again during retreatmentAPL Survival Rate and Long-Term OutlookWhat shapes the longer-term picture
Talk to us
Facing a positive gene test?
Share the first treatment summary and the new reports. CION's haematology team will explain the options and help coordinate the next step. One helpline serves every CION centre.